NASDAQ:DRIO

DarioHealth (DRIO) Stock Forecast, Price & News

$3.28

+0.05 (+1.55%)

(As of 09/29/2023 ET)

Compare

Today's Range: $3.16
▼
$3.30
50-Day Range: $2.60
▼
$3.74
52-Week Range: $2.55
▼
$6.78

Volume: 45,482 shs
Average Volume: 93,622 shs
Market Capitalization: $89.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.03

DarioHealth MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 83.9% Upside
$6.03 Price Target
Short Interest: Bearish
6.02% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.68
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.98) to ($1.66) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Medical Sector

872nd out of 972 stocks

Diagnostics & Research Industry

2nd out of 2 stocks

3.5

Analyst's Opinion

Consensus Rating
DarioHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.03, DarioHealth has a forecasted upside of 83.9% from its current price of $3.28.
Amount of Analyst Coverage
DarioHealth has only been the subject of 2 research reports in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
6.02% of the outstanding shares of DarioHealth have been sold short.
Short Interest Ratio / Days to Cover
DarioHealth has a short interest ratio ("days to cover") of 14.9, which indicates bearish sentiment.
Change versus previous month
Short interest in DarioHealth has recently increased by 2.50%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
DarioHealth does not currently pay a dividend.
Dividend Growth
DarioHealth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DRIO.

3.2

News and Social Media Coverage

News Sentiment
DarioHealth has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for DarioHealth this week, compared to 1 article on an average week.
Search Interest
7 people have searched for DRIO on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
MarketBeat Follows
10 people have added DarioHealth to their MarketBeat watchlist in the last 30 days. This is an increase of 900% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DarioHealth insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.40% of the stock of DarioHealth is held by insiders.
Percentage Held by Institutions
Only 33.31% of the stock of DarioHealth is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for DarioHealth are expected to grow in the coming year, from ($1.98) to ($1.66) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of DarioHealth is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of DarioHealth is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
DarioHealth has a P/B Ratio of 1.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About DarioHealth (NASDAQ:DRIO) Stock

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its user-centric multi-chronic condition digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move to address most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DRIO Price History

30 days | 90 days | 365 days | Advanced Chart

DRIO Stock News Headlines

September 27, 2023 | finance.yahoo.com

Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs

September 27, 2023 | finance.yahoo.com

DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 50% Below Their Intrinsic Value Estimate

October 1, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

September 26, 2023 | americanbankingnews.com

DarioHealth (NASDAQ:DRIO) Share Price Passes Below 50-Day Moving Average of $3.25

August 24, 2023 | finance.yahoo.com

Dario Publishes New Research Demonstrating Greater Engagemenet and Improved Clinical Outcomes Sustainable for Two Years

August 17, 2023 | markets.businessinsider.com

LifeSci Capital Keeps Their Buy Rating on DarioHealth (DRIO)

August 15, 2023 | finance.yahoo.com

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

August 12, 2023 | finance.yahoo.com

Some DarioHealth Corp. (NASDAQ:DRIO) Analysts Just Made A Major Cut To Next Year's Estimates

October 1, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

August 11, 2023 | msn.com

Alliance Global Partners Maintains DarioHealth (DRIO) Buy Recommendation

August 11, 2023 | finance.yahoo.com

DarioHealth Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

August 10, 2023 | markets.businessinsider.com

Here's what Wall Street expects from DarioHealth's earnings

August 10, 2023 | finanznachrichten.de

DarioHealth Corp.: DarioHealth Reports Second Quarter 2023 Financial and Operating Results

August 10, 2023 | finance.yahoo.com

DarioHealth Reports Second Quarter 2023 Financial and Operating Results

August 8, 2023 | finance.yahoo.com

Dario Expands Partnership with Large Regional Health Plan

August 4, 2023 | finance.yahoo.com

The past five years for DarioHealth (NASDAQ:DRIO) investors has not been profitable

August 3, 2023 | finance.yahoo.com

DarioHealth to Report Second Quarter 2023 Results on Thursday, August 10th

August 3, 2023 | markets.businessinsider.com

DarioHealth (DRIO) Gets a Buy from LifeSci Capital

August 2, 2023 | finance.yahoo.com

Dario Introduces GLP-1 Behavior Change Program to Help Achieve Weight Loss Goals and Better Overall Health Outcomes

July 26, 2023 | msn.com

Stifel Maintains DarioHealth (DRIO) Buy Recommendation

July 26, 2023 | finance.yahoo.com

New Research Shows $5,077 in Medical Costs Savings for Dario Users

July 24, 2023 | markets.businessinsider.com

LifeSci Capital Reaffirms Their Buy Rating on DarioHealth (DRIO)

July 24, 2023 | finance.yahoo.com

Dario Launches Agreement with Large Regional Health Plan and Announces Preliminary Results for Second Quarter of 2023 as well as Business Update

July 8, 2023 | finance.yahoo.com

DRIO - DarioHealth Corp.

July 6, 2023 | finance.yahoo.com

Dario Announces New Full Suite Employer Contract

June 26, 2023 | finance.yahoo.com

New Research Demonstrates 2.3 Point Reduction in HbA1c for Dario Digital Health Users with Baseline HbA1c Greater Than 9 points

June 14, 2023 | markets.businessinsider.com

Pre-market Movers: EAST, CNVS, DRIO, AGRX, IVA…

See More Headlines

Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Company Calendar

Last Earnings: 8/10/2023
Today: 9/30/2023
Next Earnings (Estimated): 11/13/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:DRIO
CUSIP: N/A
CIK: 1533998
Web: www.mydario.com
Phone: (833) 914-3796
Fax: 972-4770-4059
Employees: 241
Year Founded: 2011

Price Target and Rating

Average Stock Price Forecast: $6.03
High Stock Price Forecast: $8.00
Low Stock Price Forecast: $4.10
Forecasted Upside/Downside: +83.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.28)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-62,190,000.00
Net Margins: -120.19%
Pretax Margin: -216.49%
Return on Equity: -40.09%
Return on Assets: -27.20%

Debt

Debt-to-Equity Ratio: 0.37
Current Ratio: 8.14
Quick Ratio: 7.41

Sales & Book Value

Annual Sales: $27.66 million
Price / Sales: 3.23
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.12 per share
Price / Book: 1.05

Miscellaneous

Outstanding Shares: 27,230,000
Free Float: 24,670,000
Market Cap: $89.31 million
Optionable: Not Optionable
Beta: 1.37

Social Links

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Erez Raphael (Age 50)
CEO & Director
Comp: $978.76k

Mr. Richard A. Anderson (Age 54)
Pres
Comp: $998.42k

Mr. Zvi Ben David (Age 62)
CFO, Treasurer & Sec.
Comp: $429.05k

Dov Oppenheim
Co-Founder & Production Chief

Josh Fischer
Sr. VP of Operations & Compliance

Claudia Levi
Content & Communications Mang.

Mary Mooney
VP of Marketing

Limor Drezner
VP HR & Chief of Staff

Mr. Olivier R. Jarry (Age 62)
Sr. VP of Strategy & Bus. Devel.

Mr. Jean Christophe Muyl
Head of Commercialization North America

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DRIO Stock - Frequently Asked Questions

Should I buy or sell DarioHealth stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DarioHealth in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DRIO shares.
View DRIO analyst ratings or view top-rated stocks.
What is DarioHealth's stock price forecast for 2023?: 2 analysts have issued twelve-month price objectives for DarioHealth's stock. Their DRIO share price forecasts range from $4.10 to $8.00. On average, they anticipate the company's share price to reach $6.03 in the next year. This suggests a possible upside of 83.9% from the stock's current price.
View analysts price targets for DRIO or view top-rated stocks among Wall Street analysts.
How have DRIO shares performed in 2023?: DarioHealth's stock was trading at $4.28 on January 1st, 2023. Since then, DRIO shares have decreased by 23.4% and is now trading at $3.28.
View the best growth stocks for 2023 here.
When is DarioHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our DRIO earnings forecast.
How were DarioHealth's earnings last quarter?: DarioHealth Corp. (NASDAQ:DRIO) announced its earnings results on Thursday, August, 10th. The company reported ($0.58) earnings per share for the quarter, missing analysts' consensus estimates of ($0.52) by $0.06. The firm earned $6.15 million during the quarter, compared to the consensus estimate of $6.04 million. DarioHealth had a negative trailing twelve-month return on equity of 40.09% and a negative net margin of 120.19%.
What guidance has DarioHealth issued on next quarter's earnings?: DarioHealth updated its second quarter 2023 earnings guidance on Monday, July, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.00 million-$6.15 million, compared to the consensus revenue estimate of $6.73 million.

What other stocks do shareholders of DarioHealth own?: Based on aggregate information from My MarketBeat watchlists, some companies that other DarioHealth investors own include Aeterna Zentaris (AEZS), Vascular Biogenics (VBLT), Nano Dimension (NNDM), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), AbbVie (ABBV), Gilead Sciences (GILD), ADMA Biologics (ADMA) and Avadel Pharmaceuticals (AVDL).
What is DarioHealth's stock symbol?: DarioHealth trades on the NASDAQ under the ticker symbol "DRIO."
How do I buy shares of DarioHealth?: Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is DarioHealth's stock price today?: One share of DRIO stock can currently be purchased for approximately $3.28.
How much money does DarioHealth make?: DarioHealth (NASDAQ:DRIO) has a market capitalization of $89.31 million and generates $27.66 million in revenue each year. The company earns $-62,190,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.
How many employees does DarioHealth have?: The company employs 241 workers across the globe.
Does DarioHealth have any subsidiaries?: The following companies are subsidiares of DarioHealth: Labstyle Innovation Ltd., PsyInnovations Inc., PsyInnovations India Private Limited., Upright Technologies Inc., and Upright Technologies Ltd..
Read More
How can I contact DarioHealth?: DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The official website for the company is www.mydario.com. The company can be reached via phone at (833) 914-3796, via email at ir@mydario.com, or via fax at 972-4770-4059.

This page (NASDAQ:DRIO) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial